Patent Application
App. No. 13/800,175
TISSUE ENGINEERED BLOOD VESSEL
Loading inventors, assignments & file history…
Abstract
Compositions and methods of using tissue engineered blood vessels to repair and regenerate blood vessels of patients with vascular disease are disclosed.
Claims (14)
1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . A method of making a tissue engineered blood vessel comprising the steps of:
a. Providing a tubular shaped scaffold comprising poly(p-dioxanone);
b. Applying said scaffold with cell lysate; and then
c. Lyophilizing the scaffold.
8 . The method of claim 7 further comprising the steps of:
a. applying one or more of cells and minced tissue to the cell lysate scaffold; and
b. culturing the cell lysate scaffold having one or more of cells and minced tissue in a bioreactor.
9 . (canceled)
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 27, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042169/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 24, 2017
From: ETHICON, INC.
To: CORDIS CORPORATION
Reel/Frame 042123/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 20, 2017
From: COOPER, KEVIN; CHUN, IKSOO; COLTER, DAVID C; DHANARAJ, SRIDEVI; GOSIEWSKA, ANNA; SEYDA, AGNIESZKA; FANG, CARRIE H.; YANG, CHUNLIN
To: ETHICON, INC.
Reel/Frame 042078/0469 →